| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $137.2M | -14.1% |
| Cost of Revenue | $33.1M | -3.2% |
| Gross Profit | $104.1M | -17.1% |
| R&D Expense | $1.0M | -16.7% |
| SG&A Expense | $27.5M | -6.7% |
| Operating Income | -$405K | -104.5% |
| Pre-tax Income | -$479K | -105.4% |
| Income Tax | $4.0M | +522.2% |
| Net Income | -$4.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.8M | -43.0% |
| Accounts Receivable | $218K | +142.2% |
| Inventory | $14.7M | +22.5% |
| Current Assets | $35.0M | -18.4% |
| Total Assets | $49.1M | -17.6% |
| Current Liabilities | $29.8M | -0.9% |
| Total Liabilities | $35.0M | -0.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | -124.1% |
| Capital Expenditures | $1.1M | +63.5% |
| Investing Cash Flow | -$1.1M | -63.5% |
| Financing Cash Flow | -$4.3M | +53.4% |
| Free Cash Flow | -$3.7M | -136.2% |
| -145.6% |
| EPS (Basic) | -$2.35 | -147.5% |
| EPS (Diluted) | -$2.35 | -149.9% |
| Stockholders' Equity |
| $14.2M |
| -41.9% |